MetaCap

Jazz Pharmaceuticals Statistics

NASDAQ: JAZZHealth CareBiotechnology: Pharmaceutical PreparationsUSD

231.19-0.20 (-0.09%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

After hours: 231.19 0.00%

Jazz Pharmaceuticals by the numbers

Jazz Pharmaceuticals has a market capitalization of $15.01 billion based on 64.91M shares outstanding. Its trailing P/E ratio is 15.8, below the 4-company peer median of 88.5, and its forward P/E is 8.9. The stock trades 6.2% below its 50-day average and 8.8% above its 200-day average.

Average daily trading volume is 854.88K shares, or about $197.6 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

JAZZ valuation vs. peer median

JAZZ compared with the median of 8 peer companies
MetricJAZZPeer medianDifference
Market cap$15.01B$12.10B+24%
P/E (TTM)15.888.5-82%
Forward P/E8.920.1-56%
Avg. volume854.88K2.38M-64%

Peer median across 8 companies: ASND, SMMT, BBIO, CORT, MDGL, ELAN, BMRN, RDY.

Valuation

Market cap
$15.01B
Price / sales (latest FY)
3.52
EPS (TTM)
$14.59

Price and trading

Previous close
231.39
Open
229.62
Day range
227.00 – 235.54
52-week range
128.80 – 266.38
52-week change
+69.88%
Beta
—
Volume
578.90K

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
15.01B
Pe
15.85
Forward Pe
8.93
Eps
14.59
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
266.38
Week52 Low
128.80
Avg Volume
854.88K
Shares Outstanding
64.91M
Ma50
246.38
Ma200
212.58
Earnings Date
Nov 4, 2026
Pct From52w High
-13.21%
Pct From52w Low
79.50%

Related